Gene therapy for colon cancer. (Q40849028)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Gene therapy for colon cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

Ralf Michael Zwacka

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Zwacka RM

series ordinal

1

1 reference

24 September 2017

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

595-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

Regulation of the human hsp70 promoter by p53

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Lymphokines and cytokines as cancer treatment. Immunotherapy realized

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Treatment of colorectal cancer: hepatic metastasis

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

CEA-containing immune complexes in sera of patients with colorectal and breast cancer--analysis of complexed immunoglobulin classes

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Cytokines: structure, function and synthesis.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

T antigen is bound to a host protein in SY40-transformed cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Active-specific immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

The development of new immunotherapies for the treatment of cancer using interleukin-2. A review

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Augmented antitumor effects of killer cells induced by tumor necrosis factor gene-transduced autologous tumor cells from gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Carcinoembryonic antigen gene family: molecular biology and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

Hypoxia enhances stimulus-dependent induction of E-selectin on aortic endothelial cells.

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(05)70010-1

7 January 2021

10.1016/S0889-8588(05)70010-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9684100 AND SRC:MED&resulttype=core&format=json

13 November 2019

1 reference